The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells.
about
The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The tyrosine kinase inhibitor ...... drenocortical carcinoma cells.
@en
The tyrosine kinase inhibitor ...... drenocortical carcinoma cells.
@nl
type
label
The tyrosine kinase inhibitor ...... drenocortical carcinoma cells.
@en
The tyrosine kinase inhibitor ...... drenocortical carcinoma cells.
@nl
prefLabel
The tyrosine kinase inhibitor ...... drenocortical carcinoma cells.
@en
The tyrosine kinase inhibitor ...... drenocortical carcinoma cells.
@nl
P2093
P2860
P1476
The tyrosine kinase inhibitor ...... adrenocortical carcinoma cells
@en
P2093
Elaine Silveira
Isadora Pontes Cavalcante
Jean Lucas Kremer
Pedro Omori Ribeiro de Mendonça
P2860
P2888
P356
10.1186/S12935-018-0527-X
P50
P577
2018-03-01T00:00:00Z
P6179
1101279255